Critical roles of the miR-17～92 family in thymocyte development, leukemogenesis, and autoimmunity

MHC class II regulation of CD8+T cell tolerance and implications in autoimmunity and cancer immunotherapy

The miR-17～92 miRNAs promote plasma cell differentiation by suppressing SOCS3-mediated NIK degradation

Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation

Dhx33 promotes B-cell growth and proliferation by controlling activation-induced rRNA upregulation

A p38 alpha-BLIMP1 signalling pathway is essential for plasma cell differentiation

Myc inhibition tips the immune balance to promote antitumor immunity

Analysis of a miR-148a Targetome in B Cell Central Tolerance

Mitochondrial C1qbp promotes differentiation of effector CD8(+) T cells via metabolic-epigenetic reprogramming

Glycogen synthase kinase 3 drives thymocyte egress by suppressing beta-catenin activation of Akt

GSK3 Restrains Germinal Center B Cells to Form Plasma Cells

Ascorbic Acid Promotes Plasma Cell Differentiation through Enhancing TET2/3-Mediated DNA Demethylation

MicroRNA control of B cell tolerance, autoimmunity and cancer

Endothelial Scaffolding Protein ENH (Enigma Homolog Protein) Promotes PHLPP2 (Pleckstrin Homology Domain and Leucine-Rich Repeat Protein Phosphatase 2)-Mediated Dephosphorylation of AKT1 and eNOS (Endothelial NO Synthase) Promoting Vascular Remodeling

CCL4 enhances blinatumomab therapy in a human B-ALL xenograft mouse model

Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies (vol 33, pg 2315, 2019)

Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies

MicroRNA says no to mass production

Differential Sensitivity of Target Genes to Translational Repression by miR-17 similar to 92

A miR-155-Peli1-c-Rel pathway controls the generation and function of T follicular helper cells

MicroRNA-17 similar to 92 inhibits colorectal cancer progression by targeting angiogenesis